関連する実験動画
Updated: Jan 23, 2026

09:39
Mapping Dysfunctional Protein-Protein Interactions in Disease
Published on: October 24, 2025
706
FRMD3の構造不安定化はFERMドメイン変異により引き起こされ、オリゴデンドロサイト機能不全を介して低髄鞘形成疾患を引き起こす
Diksha1, Abhishek Kumar2, Smita Saha3
1All India Institute of Medical Sciences, Rishikesh 249203, India.
ACS chemical neuroscience
|January 21, 2026
まとめ
新規FRMD3遺伝子変異は、タンパク質を不安定化させ、凝集を引き起こし、オリゴデンドロサイト機能を損なうことにより、低髄鞘形成疾患を引き起こします。この発見は、FRMD3を神経発達障害の新たな候補遺伝子として特定します。
科学分野:
- 神経遺伝学
- 分子生物学
- 発生神経科学
背景:
- 低髄鞘形成疾患は、遺伝的要因による髄鞘形成または維持の障害を伴うまれな神経発達障害です。
- これらの病状の遺伝的基礎を特定することは、疾患メカニズムの理解と治療法の開発に不可欠です。
研究 の 目的:
- 小児患者に関連するFRMD3遺伝子の新規ホモ接合性ミスセンス変異を調査すること。
- FRMD3変異が神経発達病理を引き起こす分子メカニズムを解明すること。
主な方法:
- FRMD3変異(c.898T > C; p.C300R)を特定するための遺伝子シーケンシング。
- タンパク質の構造と安定性を評価するための分子動力学シミュレーションと生物物理学的分析。
- タンパク質機能を評価するための細胞アッセイ(凝集研究およびオリゴデンドロサイトにおけるFRMD3レスキュー実験を含む)。
- FRMD3の細胞局在と相互作用をマッピングするためのインタクトームおよび単一細胞発現分析。
主要な成果:
- 特定されたFRMD3変異(p.C300R)は、FERMドメインを不安定化させ、タンパク質凝集を増加させ、細胞モデルでミスローカライゼーションを引き起こします。
- 変異型FRMD3はオリゴデンドロサイトの神経突起形成を阻害し、髄鞘タンパク質(PLP1、MBP)の発現を回復できません。
- FRMD3は、オリゴデンドロサイト機能に不可欠な膜輸送および脂質処理経路に関与しています。
結論:
- FRMD3は低髄鞘形成疾患の新規候補遺伝子です。
- FRMD3の構造不安定化と凝集はオリゴデンドロサイト機能を破壊し、髄鞘タンパク質の発現障害と局所的な低髄鞘形成につながります。
- 本研究は、神経発達プロセスにおけるタンパク質構造完全性の重要な役割を強調しています。
関連する概念動画
Mutations
94.4K
Overview
94.4K
Mutations
44.0K
Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
44.0K
Destabilization of Microtubules
3.5K
The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
3.5K
Conservation of Protein Domains Over Different Proteins
14.1K
Protein domains are small structurally independent units that are part of a single amino acid chain. Although these domains are often structurally independent, they may rely on synergistic effects to perform their functions as part of a larger protein. Protein domains may be conserved within the same organism, as well as across different organisms.
A limited set of protein domains often duplicate and recombine during evolution. These domains can be organized in different combinations to...
A limited set of protein domains often duplicate and recombine during evolution. These domains can be organized in different combinations to...
14.1K
Drugs that Destabilize Microtubules
3.7K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.7K
Viral Mutations
39.8K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
39.8K

